The Searle Company Stock Forecast for 2023 - 2025 - 2030
Updated on 03/27/2024
The Searle Company Stock Forecast and Price Target
In recent months, notable analysts have provided yearlong price targets for The Searle Company, with the average target coming in at ₨65.00. If it were to be achieved, this would result in a potential upside of approximately 18.42 percent from the most recent closing price in March, 2024. The high end is ₨65.00, and the low is ₨65.00. If you're thinking of investing in SEARL stock, it might be good to look at its rivals too.
18.42% Upside
The Searle Company Fair Value Forecast for 2023 - 2025 - 2030
The Searle Company's Price has decreased by 100.00% In the last four years, from ₨167.46 to ₨0.00. For next year, analysts predict Fair Value of ₨59.91, which would mean an increase of 100.00%. Over the next seven years, experts predict that The Searle Company's Fair Value will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$120.19 | Buy/Sell | $118.92 | 4.83% |
NOVN Stock Forecast | Novartis | Outperform |
10
|
CHF88.80 | Buy/Sell | CHF105.00 | 23.95% |
PFE Stock Forecast | Pfizer | Outperform |
2
|
$28.37 | Buy/Sell | $32.87 | 10.82% |
ABOT Stock Forecast | Abbott Laboratories (Pakistan) | - |
17
|
₨467.96 | Buy/Sell | ₨0.00 | -100.00% |
GLAXO Stock Forecast | GlaxoSmithKline Pakistan | - |
18
|
₨79.00 | Buy/Sell | ₨0.00 | -100.00% |
The Searle Company Revenue Forecast for 2023 - 2025 - 2030
In the last three years, The Searle Company's Revenue has grown by 65.56%, rising from ₨20.47B to ₨33.90B. In the following year, the 0 analysts surveyed believe that The Searle Company's Revenue will decrease by 15.34%, reaching ₨28.70B. According to professionals, by 2030, The Searle Company's Revenue will have decreased by 13.79%, falling down to ₨29.22B.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
HINOON Stock Forecast | Highnoon Laboratories | - |
18
|
₨514.46 | Buy/Sell | ₨600.07 | -100.00% |
AGP Stock Forecast | AGP | Buy |
18
|
₨72.81 | Buy/Sell | ₨100.00 | 37.34% |
FEROZ Stock Forecast | Ferozsons Laboratories | Buy |
0
|
₨237.46 | Buy/Sell | ₨325.00 | 36.87% |
The Searle Company Dividend per Share Forecast for 2023 - 2025 - 2030
In the last year, The Searle Company's Dividend per Share has decreased from ₨2.50 to ₨1.54 – a 38.40% drop! The next year, 1 experts forecast that The Searle Company's Dividend per Share will decrease by 100.00%, reaching ₨0.00. Over the next seven years, experts predict that The Searle Company's Dividend per Share will grow at a rate of 91.55%.
The Searle Company EBITDA Forecast for 2023 - 2025 - 2030
The Searle Company's EBITDA has grown In the last three years, rising from ₨4.55B to ₨5.65B – a growth of 24.22%. In the next year, analysts believe that EBITDA will reach ₨8.00B – an increase of 41.50%. For the next seven years, experts predict that The Searle Company's EBITDA will grow at a rate of 88.51%.
The Searle Company EBIT Forecast for 2023 - 2025 - 2030
The Searle Company's EBIT has seen impressive growth In the last three years, rising from ₨4.23B to ₨4.94B – a growth of 16.62%. In the next year, analysts believe that EBIT will reach ₨7.49B – an increase of 51.71%. For the next seven years, the forecast is for EBIT to grow by 155.78%.
The Searle Company EPS Price Prediction Forecast for 2023 - 2025 - 2030
The Searle Company's EPS has decreased by 100.00% In the last four years, from ₨7.24 to ₨0.00. For next year, analysts predict EPS of ₨2.59, which would mean an increase of 100.00%. Over the next seven years, experts predict that The Searle Company's EPS will grow at a rate of 100.00%.